MedGen, Inc. Stock

MDIN

US58436J1007

Pharmaceuticals

Market Closed - OTC Markets 09:35:26 2021-10-01 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		-.--%	-

20-06-24	9430075 Canada Ltd. completed the acquisition of MedGen, Inc. in a reverse merger transaction.	CI
19-10-08	9430075 Canada Ltd. entered into a letter of intent to acquire MedGen, Inc. in a reverse merger transaction.	CI

Northstar Global Business Services, Inc. is engaged in manufacturing, selling and licensing healthcare products, specifically to the market for alternative, self-help health and wellness industry. The Company's products are distributed via direct online sales, as well as retail distribution through its partners, and individual stores. Its products include SNORenz, SNORenz Night Time, Health Enrich for Pets, Stem-Intense and Wide Awake. It others products include Sombium, Focamine and Relaxapro. SNORenz is a lubricating throat spray. SNORenz Night Time is also a lubricating throat spray and natural supplement sleep aid. Health Enrich for Pets is an anti-inflammatory and a catalyst that causes the body to be flooded with adult stem cells. Stem-Intense is a supplement for producing adult stem cells. Wide Awake is an energy spray and breath freshener. Sombium is a chemical-free sleep aid. Focamine is a concentration promoter. Relaxapro is an anti-anxiety medicine.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
MDIN Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	301K 270K 250K 226K 423K 28.67M 428K 2.99M 1.19M 15M 1.13M 1.11M 47.63M	P/E 2018 *	-	P/E 2019	-20x
Enterprise Value	325K 292K 270K 244K 457K 30.99M 462K 3.23M 1.29M 16.22M 1.22M 1.2M 51.48M	EV / Sales 2018	350x	EV / Sales 2019	310x
Free-Float	66.72%	Yield 2018 *	-	Yield 2019	-

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDGEN, INC.	-99.00%	-.--%	-	-	3.01K
ELI LILLY AND COMPANY	+0.50%	+1.38%	+57.09%	+129.96%	1,143B
JOHNSON & JOHNSON	+0.86%	+5.14%	+45.00%	+86.15%	647B
ABBVIE INC.	-0.14%	+0.42%	+25.69%	+105.85%	506B
ROCHE HOLDING AG	-0.05%	+1.73%	+52.74%	+67.74%	384B
MERCK & CO., INC.	-0.63%	-5.97%	+61.93%	+37.06%	350B
NOVARTIS AG	+0.34%	+1.84%	+30.70%	+54.27%	293B
ASTRAZENECA PLC	-0.45%	+1.19%	+2.89%	+26.08%	265B
AMGEN INC.	+0.87%	+3.08%	+54.69%	+72.74%	242B
GILEAD SCIENCES, INC.	+0.08%	+3.67%	+35.05%	+107.78%	197B
Average	-9.76%	+1.30%	+40.64%	+76.40%	402.75B
Weighted average by Cap.	+0.25%	+1.55%	+44.50%	+89.02%

	2018	2019
Net sales	900 807.48 746.55 676.12 1.26K 85.72K 1.28K 8.93K 3.56K 44.85K 3.38K 3.31K 142K	1.05K 942.96 871.8 789.56 1.48K 100K 1.49K 10.42K 4.15K 52.38K 3.94K 3.86K 166K
Net income	-11.02K -9.88K -9.14K -8.28K -15.46K -1.05M -15.65K -109K -43.51K -549K -41.33K -40.46K -1.74M	-15.54K -13.94K -12.89K -11.67K -21.81K -1.48M -22.07K -154K -61.38K -774K -58.31K -57.08K -2.46M
Net Debt	13.9K 12.47K 11.53K 10.44K 19.5K 1.32M 19.74K 138K 54.9K 693K 52.15K 51.05K 2.2M	24.36K 21.86K 20.21K 18.3K 34.19K 2.32M 34.61K 242K 96.24K 1.21M 91.42K 89.49K 3.85M

MedGen, Inc. Stock

Stocks

MDIN

US58436J1007

Pharmaceuticals

Valuation: MedGen, Inc.

Latest news: MedGen, Inc.

Press Releases: MedGen, Inc.

Quotes and Performance

Price Extremes

Generic Pharmaceuticals

Financials

Company Profile